M S Co
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
Papers in
-
- Protein purification and stability 4
- Glycosylation and Glycoproteins Research 3
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Cary Queen (5 shared papers)Bernard N. Fields (3 shared papers)Glen N. Gaulton (3 shared papers)N M Avdalovic (4 shared papers)M I Greene (2 shared papers)Philip Caron (2 shared papers)David A. Scheinberg (2 shared papers)Marina Deschamps (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (5 papers)The Journal of Immunology (2 papers)Journal of Immunotherapy (1 paper)Journal of the American Chemical Society (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
M S Co
17 papers receiving 954 citations
Peers
Comparison fields: 5 of 81
- Radiology, Nuclear Medicine and Imaging 416
- Infectious Diseases 201
- Immunology 218
- Immunology and Allergy 58
- Hematology 84
Countries citing papers authored by M S Co
This map shows the geographic impact of M S Co's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M S Co with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M S Co more than expected).
Fields of papers citing papers by M S Co
This network shows the impact of papers produced by M S Co. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M S Co. The network helps show where M S Co may publish in the future.
Co-authors
The 25 scholars most cited alongside M S Co, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 126 | |
| 2 | 1992 | 118 | |
| 3 | 1988 | 113 | |
| 4 | Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies. | 1992 | 108 |
| 5 | 1991 | 96 | |
| 6 | 1985 | 94 | |
| 7 | 1985 | 73 | |
| 8 | 1981 | 61 | |
| 9 | 1993 | 49 | |
| 10 | Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys. | 1996 | 39 |
| 11 | 1992 | 36 | |
| 12 | 1994 | 31 | |
| 13 | 1984 | 26 | |
| 14 | 1994 | 19 | |
| 15 | 1982 | 17 | |
| 16 | 1984 | 6 | |
| 17 | 1992 | 2 |
About M S Co
M S Co is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Genetics and Pathology and Forensic Medicine, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Protein purification and stability (4 papers), Glycosylation and Glycoproteins Research (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Cell Adhesion Molecules Research (2 papers), Transgenic Plants and Applications (2 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (416 citations), Infectious Diseases (201 citations), Immunology (218 citations), Immunology and Allergy (58 citations) and Hematology (84 citations). M S Co has collaborated with scholars based in United States and Japan. Frequent co-authors include Cary Queen, Bernard N. Fields, Glen N. Gaulton, N M Avdalovic, M I Greene, Philip Caron, David A. Scheinberg, Marina Deschamps, Richard J. Whitley and Max L. Nibert. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology, Journal of Immunotherapy, Journal of the American Chemical Society and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.